相关实验视频
Updated: Jan 10, 2026

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.5K
危急病患者红细胞输血后的血静变化:一项回顾性队列研究
1Department of Anesthesiology and Intensive Care, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.
Journal of clinical medicine
|November 27, 2025
概括
红细胞 (RBC) 输血可能会削弱凝块结构,并减少严重病患者的凝块分解. 传统的凝血测试往往无法检测出这些静血变化,这强调了对粘弹性监测的需要.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 输血医学 输血医学
背景情况:
- 红细胞 (RBC) 在血液静止中起着积极的作用,影响血小板激活,血栓生成和凝块结构.
- 红细胞输血可以改变凝血动态,但这些效应通常不会被传统的凝血测试检测到.
- 粘弹性监测对于评估红细胞输血的静血影响至关重要.
研究的目的:
- 为了研究单单单元红细胞输血对严重贫血患者的静血效应.
- 在检测输血相关的静血变化方面,比较旋转血栓形成显微镜 (ROTEM) 与常规凝血试验的灵敏度.
主要方法:
- 在重症监护病房进行回顾性单中心研究.
- 分析ROTEM,常规凝血测试,和完整血清 (CBC) 数据在RBC输血前后的数据.
- 评估血小板和纤维素原对凝块强度的贡献.
主要成果:
- ROTEM分析表明,红细胞输血后纤维素对凝块强度的贡献降低,红细胞输血后纤维素过量减少.
- 传统的凝血试验显示出最小的变化,D-二次体水平显著增加.
- 分析了35名患者,显示出血液静止的微妙但显著的变化.
结论:
- 在非出血,严重病的贫血患者中,单次红细胞输血可能会损害基于纤维素的凝块架构,并降低超纤维素分解.
- 传统的凝血试验不足以检测红细胞输血的大部分静血效应.
- 需要进一步的机制研究才能充分了解红细胞输血的净静血影响.
相关概念视频
Blood Transfusion and Agglutination
14.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.0K
Blood Transfusion
2.1K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.1K
Venous Thrombosis IV: Nursing Management
188
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
188
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Introduction to Hemostasis
13.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.1K
Extrinsic and Intrinsic Pathways of Hemostasis
11.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.9K

